
Alana Harris Dent
Examiner (ID: 7014)
| Most Active Art Unit | 1643 |
| Art Unit(s) | 1643, 1642 |
| Total Applications | 1512 |
| Issued Applications | 526 |
| Pending Applications | 351 |
| Abandoned Applications | 660 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5533005
[patent_doc_number] => 20090232793
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-17
[patent_title] => 'Elastase inhibitor and acute leukemia'
[patent_app_type] => utility
[patent_app_number] => 11/658967
[patent_app_country] => US
[patent_app_date] => 2005-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11041
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20090232793.pdf
[firstpage_image] =>[orig_patent_app_number] => 11658967
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/658967 | Elastase inhibitor and acute leukemia | Aug 3, 2005 | Abandoned |
Array
(
[id] => 5596237
[patent_doc_number] => 20060160154
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-20
[patent_title] => 'Materials and methods for detection and treatment of breast cancer'
[patent_app_type] => utility
[patent_app_number] => 11/194051
[patent_app_country] => US
[patent_app_date] => 2005-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 16756
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20060160154.pdf
[firstpage_image] =>[orig_patent_app_number] => 11194051
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/194051 | Materials and methods for detection and treatment of breast cancer | Jul 28, 2005 | Abandoned |
Array
(
[id] => 4561195
[patent_doc_number] => 07846456
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-12-07
[patent_title] => 'Methods for breast treatment'
[patent_app_type] => utility
[patent_app_number] => 11/192777
[patent_app_country] => US
[patent_app_date] => 2005-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16645
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/846/07846456.pdf
[firstpage_image] =>[orig_patent_app_number] => 11192777
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/192777 | Methods for breast treatment | Jul 28, 2005 | Issued |
Array
(
[id] => 17119667
[patent_doc_number] => 11130789
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-28
[patent_title] => Urine markers for detection of bladder cancer
[patent_app_type] => utility
[patent_app_number] => 11/658220
[patent_app_country] => US
[patent_app_date] => 2005-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 73
[patent_figures_cnt] => 54
[patent_no_of_words] => 13773
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11658220
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/658220 | Urine markers for detection of bladder cancer | Jul 21, 2005 | Issued |
Array
(
[id] => 17119667
[patent_doc_number] => 11130789
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-28
[patent_title] => Urine markers for detection of bladder cancer
[patent_app_type] => utility
[patent_app_number] => 11/658220
[patent_app_country] => US
[patent_app_date] => 2005-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 73
[patent_figures_cnt] => 54
[patent_no_of_words] => 13773
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11658220
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/658220 | Urine markers for detection of bladder cancer | Jul 21, 2005 | Issued |
Array
(
[id] => 5655224
[patent_doc_number] => 20060140959
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-29
[patent_title] => 'Old-35, a gene associated with senescence and terminal cell differentiation, and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/186718
[patent_app_country] => US
[patent_app_date] => 2005-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 60
[patent_figures_cnt] => 60
[patent_no_of_words] => 20493
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0140/20060140959.pdf
[firstpage_image] =>[orig_patent_app_number] => 11186718
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/186718 | Old-35, a gene associated with senescence and terminal cell differentiation, and uses thereof | Jul 20, 2005 | Abandoned |
Array
(
[id] => 4657549
[patent_doc_number] => 20080026410
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-31
[patent_title] => 'Biomarkers for Bladder Cancer'
[patent_app_type] => utility
[patent_app_number] => 11/632423
[patent_app_country] => US
[patent_app_date] => 2005-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 15540
[patent_no_of_claims] => 86
[patent_no_of_ind_claims] => 33
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20080026410.pdf
[firstpage_image] =>[orig_patent_app_number] => 11632423
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/632423 | Biomarkers for Bladder Cancer | Jul 19, 2005 | Abandoned |
Array
(
[id] => 101440
[patent_doc_number] => 07727528
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-01
[patent_title] => 'Methods for diagnosis using anti-cytokine receptor antibodies'
[patent_app_type] => utility
[patent_app_number] => 11/185335
[patent_app_country] => US
[patent_app_date] => 2005-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4566
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/727/07727528.pdf
[firstpage_image] =>[orig_patent_app_number] => 11185335
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/185335 | Methods for diagnosis using anti-cytokine receptor antibodies | Jul 19, 2005 | Issued |
Array
(
[id] => 4779311
[patent_doc_number] => 20080287309
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-20
[patent_title] => 'Methods for Discovering Antibodies Specific to Cancer Cells and Antibodies Discovered Thereby'
[patent_app_type] => utility
[patent_app_number] => 11/631911
[patent_app_country] => US
[patent_app_date] => 2005-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9068
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20080287309.pdf
[firstpage_image] =>[orig_patent_app_number] => 11631911
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/631911 | Methods for Discovering Antibodies Specific to Cancer Cells and Antibodies Discovered Thereby | Jul 7, 2005 | Abandoned |
Array
(
[id] => 5501627
[patent_doc_number] => 20090162315
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-25
[patent_title] => 'Enterotoxin gene cluster (egc) superantigens to treat malignant disease'
[patent_app_type] => utility
[patent_app_number] => 11/571188
[patent_app_country] => US
[patent_app_date] => 2005-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 67977
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 28
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20090162315.pdf
[firstpage_image] =>[orig_patent_app_number] => 11571188
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/571188 | Enterotoxin gene cluster (egc) superantigens to treat malignant disease | Jun 26, 2005 | Abandoned |
Array
(
[id] => 7055585
[patent_doc_number] => 20050276758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-15
[patent_title] => 'Method for screening agents against human prostate disease'
[patent_app_type] => utility
[patent_app_number] => 11/150066
[patent_app_country] => US
[patent_app_date] => 2005-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5891
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0276/20050276758.pdf
[firstpage_image] =>[orig_patent_app_number] => 11150066
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/150066 | Method for screening agents against human prostate disease | Jun 8, 2005 | Abandoned |
Array
(
[id] => 4926987
[patent_doc_number] => 20080166350
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-10
[patent_title] => 'Genetic Products Differentially Expressed in Tumors and the Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 11/596649
[patent_app_country] => US
[patent_app_date] => 2005-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 63
[patent_figures_cnt] => 63
[patent_no_of_words] => 31770
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20080166350.pdf
[firstpage_image] =>[orig_patent_app_number] => 11596649
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/596649 | Genetic products differentially expressed in tumors and the use thereof | May 17, 2005 | Issued |
Array
(
[id] => 5590834
[patent_doc_number] => 20060040285
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-23
[patent_title] => 'Human kinase interacting protein 2 (KIP2)-related gene variant associated with cancers'
[patent_app_type] => utility
[patent_app_number] => 11/125403
[patent_app_country] => US
[patent_app_date] => 2005-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5646
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20060040285.pdf
[firstpage_image] =>[orig_patent_app_number] => 11125403
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/125403 | Human kinase interacting protein 2 (KIP2)-related gene variant associated with cancers | May 8, 2005 | Issued |
Array
(
[id] => 211400
[patent_doc_number] => 07622306
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-11-24
[patent_title] => 'Using plasma proteomic pattern for diagnosis, classification, prediction of response to therapy and clinical behavior, stratification of therapy, and monitoring disease in hematologic malignancies'
[patent_app_type] => utility
[patent_app_number] => 11/110374
[patent_app_country] => US
[patent_app_date] => 2005-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 33
[patent_no_of_words] => 14122
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 271
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/622/07622306.pdf
[firstpage_image] =>[orig_patent_app_number] => 11110374
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/110374 | Using plasma proteomic pattern for diagnosis, classification, prediction of response to therapy and clinical behavior, stratification of therapy, and monitoring disease in hematologic malignancies | Apr 19, 2005 | Issued |
Array
(
[id] => 4852469
[patent_doc_number] => 20080318212
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-25
[patent_title] => 'Orphan Receptor Tyrosine Kinase as a Target in Breast Cancer'
[patent_app_type] => utility
[patent_app_number] => 11/547934
[patent_app_country] => US
[patent_app_date] => 2005-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 30669
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0318/20080318212.pdf
[firstpage_image] =>[orig_patent_app_number] => 11547934
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/547934 | Orphan Receptor Tyrosine Kinase as a Target in Breast Cancer | Apr 5, 2005 | Abandoned |
Array
(
[id] => 5165276
[patent_doc_number] => 20070286860
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-13
[patent_title] => 'Compositions and Methods for Inducing Anti-Tumor Immunity'
[patent_app_type] => utility
[patent_app_number] => 10/594259
[patent_app_country] => US
[patent_app_date] => 2005-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 33996
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20070286860.pdf
[firstpage_image] =>[orig_patent_app_number] => 10594259
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/594259 | Compositions and Methods for Inducing Anti-Tumor Immunity | Mar 24, 2005 | Abandoned |
Array
(
[id] => 5199126
[patent_doc_number] => 20070298444
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-27
[patent_title] => 'Methods and Compositions for Use in Evaluating and Treating Neoplastic Disease Conditions'
[patent_app_type] => utility
[patent_app_number] => 10/594940
[patent_app_country] => US
[patent_app_date] => 2005-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 21195
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0298/20070298444.pdf
[firstpage_image] =>[orig_patent_app_number] => 10594940
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/594940 | Methods and Compositions for Use in Evaluating and Treating Neoplastic Disease Conditions | Mar 23, 2005 | Abandoned |
Array
(
[id] => 7192975
[patent_doc_number] => 20050163768
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-28
[patent_title] => 'Monoclonal antibodies and their use'
[patent_app_type] => utility
[patent_app_number] => 11/088361
[patent_app_country] => US
[patent_app_date] => 2005-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 12794
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0163/20050163768.pdf
[firstpage_image] =>[orig_patent_app_number] => 11088361
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/088361 | Monoclonal antibodies and their use | Mar 22, 2005 | Abandoned |
Array
(
[id] => 5010460
[patent_doc_number] => 20070280939
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-06
[patent_title] => 'Prostatic Acid Phosphatase Antigens'
[patent_app_type] => utility
[patent_app_number] => 10/592928
[patent_app_country] => US
[patent_app_date] => 2005-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9320
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20070280939.pdf
[firstpage_image] =>[orig_patent_app_number] => 10592928
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/592928 | Prostatic Acid Phosphatase Antigens | Mar 16, 2005 | Abandoned |
Array
(
[id] => 5545342
[patent_doc_number] => 20090155219
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-18
[patent_title] => 'METHODS FOR DAMAGING CELLS USING EFFECTOR FUNCTIONS OF ANTI-GFRA1 ANTIBODIES'
[patent_app_type] => utility
[patent_app_number] => 11/908258
[patent_app_country] => US
[patent_app_date] => 2005-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9315
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0155/20090155219.pdf
[firstpage_image] =>[orig_patent_app_number] => 11908258
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/908258 | METHODS FOR DAMAGING CELLS USING EFFECTOR FUNCTIONS OF ANTI-GFRA1 ANTIBODIES | Mar 10, 2005 | Abandoned |